Chilblain lupus is a rare form of cutaneous lupus that causes painful, itchy red or purple patches on fingers, toes, ears, or nose after cold or damp exposure. These skin symptoms can crack or ulcerate and may burn, and a doctor may see swelling or scaly plaques. It tends to be chronic and can flare in winter and calm in warmer months. It affects adults and sometimes children, and a few people also have or later develop systemic lupus. Most people do well with protection from cold, topical steroids or calcineurin creams, and sometimes antimalarials, and the risk of death is low.
Overview
Chilblain lupusSymptoms
Early symptoms of chilblain lupus include painful, itchy red‑purple bumps on fingers, toes, or ears that worsen in cold weather. Swelling and burning are common, and cracked skin or ulcers may form; some notice numbness or color changes in cold.
Outlook and prognosis
Most people with chilblain lupus improve with cold avoidance, skin protection, and targeted treatment, though flares can recur in winter or damp weather. Skin spots usually heal over weeks, sometimes leaving slight color changes. A minority develop broader autoimmune features, so periodic check-ins help.
Causes and risk factors
Chilblain lupus stems from immune overactivity in skin, triggered by cold and damp. Key risk factors for chilblain lupus include autoimmune history or family variants (such as TREX1), female sex, Raynaud’s, smoking, and cold exposure. Having systemic lupus adds susceptibility.
Genetic influences
Genetics play a meaningful role in chilblain lupus. Variants in genes affecting immune signaling and skin’s response to cold, like TREX1, can raise risk, especially with family history. Testing is considered when symptoms start early or are severe or recurrent.
Diagnosis
Doctors diagnose Chilblain lupus from cold-triggered sores on fingers or toes, exam findings, and sometimes skin biopsy. Blood tests help confirm the diagnosis of Chilblain lupus and rule out similar conditions. In persistent cases, genetic testing may be used.
Treatment and drugs
Chilblain lupus is managed by protecting skin from cold and damp, gentle wound care, and creams to calm inflammation. Doctors may add medicines that reduce overactive immune activity or improve circulation. Regular follow-up checks for flare patterns and complications.
Symptoms
Cold, damp days can bring burning, itchy, purple spots on the fingers or toes, sometimes on the ears or nose. These cold-triggered flares are called chilblain lupus, a form of lupus that affects the skin. Early symptoms of chilblain lupus often include tingling, burning, or itch before the skin changes appear. Symptoms vary from person to person and can change over time.
Painful or itchy red-purple spots develop on fingers, toes, ears, or the nose after cold exposure. They may feel warm and tender once you come back indoors. These marks often cluster on the sides of fingers and toes in chilblain lupus.
A burning, stinging, or itchy feeling can come before any visible spots. You might notice small changes at first, like tingling that fades and returns with the cold. Many describe a pins-and-needles sensation in the affected areas.
Fingers or toes can swell and feel tight. Rings may feel stuck, and bending joints can be uncomfortable. Swelling often eases as chilblain lupus cool-weather flares settle.
Exposed skin turns sore and sensitive in cold, damp weather. Numbness may quickly flip to throbbing pain as the skin rewarms. Day to day, it can feel like even a short walk without gloves sets off your symptoms.
How people usually first notice Chilblain lupus?
Many people first notice chilblain lupus during the colder months, when red to violaceous patches or small, painful swellings appear on the fingers, toes, heels, ears, or nose after cold exposure and don’t resolve as quickly as typical chilblains. The areas may burn or itch, and over days they can develop shiny skin, scaling, cracks, or small ulcers; some notice color changes that worsen outdoors and improve with warming. Because these lesions tend to linger, recur each winter, or leave dark spots, clinicians are often consulted to evaluate whether these are simple chilblains or the first signs of chilblain lupus.
Types of Chilblain lupus
Chilblain lupus can look different from one person to the next, and doctors recognize a few patterns that show up on the skin. Some types flare in cold, damp weather, while others linger year-round on toes, fingers, ears, or the nose. People may notice color changes, swelling, and tender or itchy patches that can crack or form small sores. Clinicians often describe them in these categories:
Primary skin-limited
Lesions appear on acral areas like fingers, toes, heels, or ears without signs of internal organ involvement. Patches often turn red to violaceous, feel tender or itchy, and may worsen in cold and damp conditions. Early symptoms of chilblain lupus can resemble common chilblains but last longer and heal more slowly.
Systemic-associated
Similar skin changes occur in someone who also has systemic lupus features such as joint pain, fatigue, or specific lab markers. Skin flares can track with overall lupus activity and may be more persistent. Not everyone will experience every type.
Pernio-like overlap
Lesions closely mimic idiopathic pernio (chilblains) but show features of lupus on biopsy or blood tests. Symptoms often surge in winter, with swelling, burning, and color changes on toes and fingers. Keeping track of which type you experience most can help.
Chronic recurrent
Lesions last more than a few months or return seasonally over several years. The skin can develop scaling, cracks, or small ulcers that heal with darkened spots or mild scars. For many, certain types stand out more than others.
What genetics can tell you about symptoms
Certain TREX1 gene variants are linked to chilblain lupus, causing painful, itchy red-purple patches on fingers, toes, ears, or nose that worsen with cold exposure. These variants disrupt DNA cleanup in skin cells, triggering immune overactivity and inflammation that damages small blood vessels.
Causes and risk factors
Cold and damp weather and poor circulation are common triggers for chilblain lupus, and early symptoms of chilblain lupus often follow a cold snap. The immune system can overreact in the skin and small blood vessels, and some people also live with cutaneous or systemic lupus. Some risks are modifiable (things you can change), others are non-modifiable (things you can’t). Modifiable risks include smoking, repeated cold exposure, tight footwear, and standing in damp conditions. Non-modifiable risks include family history, being female at birth, Raynaud’s, and rare inherited gene changes such as TREX1 or SAMHD1.
Environmental and biological risk factors
When days turn cold and damp, chilblain lupus tends to flare where blood flow is most fragile—often fingers, toes, ears, or the nose. People often notice early symptoms of chilblain lupus soon after the first cold snaps. Doctors often group risks into internal (biological) and external (environmental). Below are key environmental and biological risk factors for chilblain lupus.
Non-freezing cold plus moisture makes surface blood vessels clamp down and leak. This raises the chance of chilblain lupus lesions. Risk often climbs in late autumn and winter.
Cold wind strips heat from exposed skin faster than still air. That extra cooling can trigger chilblain lupus even when the air temperature is just above freezing. Short trips outdoors on windy days may be enough.
Going quickly from cold outdoors into warmth stresses the skin’s tiny vessels. The rapid swing can ignite the inflammation seen in chilblain lupus. Episodes often start within minutes of coming inside.
Damp gloves, socks, or sleeves keep skin colder for longer. Prolonged wetness increases the risk of chilblain lupus on fingers and toes. This often follows rain, snow, or sweat that doesn’t dry.
Genetic risk factors
Chilblain lupus can run in families and, in some, is driven by rare changes in genes that control the body’s antiviral alarm system (type I interferon). Carrying a genetic change doesn’t guarantee the condition will appear. Researchers have identified several genetic risk factors for Chilblain lupus, most involving pathways that clear stray DNA or keep interferon signals in check. These variants can explain early-onset cases and why symptoms differ among relatives.
TREX1 variants: Rare changes in the TREX1 gene are a well-recognized cause of familial Chilblain lupus. One changed copy can be enough to increase risk, and severity can vary within a family. Some carriers never develop skin lesions.
SAMHD1 variants: Inheriting harmful changes in both copies of SAMHD1 has been linked to Chilblain lupus. This recessive pattern often starts in childhood. Parents carrying one copy typically have no symptoms.
Interferon pathway genes: Genes that amplify the body’s type I interferon alarm can raise the chance of Chilblain lupus. Overactive signaling can push the skin’s immune cells to inflame fingers, toes, ears, or nose. These pathways connect Chilblain lupus to other interferon-related conditions.
Family history: Having close relatives with Chilblain lupus or related interferon-driven conditions increases the likelihood of a genetic form. This pattern can point to an inherited variant in the same pathway. The exact risk depends on which gene is involved.
Inheritance patterns: Some families show a pattern where one changed copy is enough to pass on risk, while others require two changed copies. This explains why multiple generations may be affected in some families but not in others. A genetics professional can clarify your family’s pattern.
Incomplete penetrance: Not everyone who carries a risk variant will develop Chilblain lupus. This helps explain different experiences among relatives who have the same change. Severity can range from occasional minor lesions to more persistent skin changes.
Early-onset clues: When Chilblain lupus begins in infancy or childhood, a single-gene cause is more likely. This timing often points to variants that strongly activate interferon signaling. Families with early cases may benefit from genetics input.
Lifestyle risk factors
Lifestyle choices can influence how often Chilblain lupus flares occur and how quickly lesions heal. The following elements highlight lifestyle risk factors for Chilblain lupus and practical ways they may affect symptoms. These points focus on day-to-day habits that influence microcirculation, skin integrity, inflammation, and recovery.
Nicotine narrows small blood vessels, reducing flow to fingers and toes and worsening lesion severity. Quitting can improve microcirculation and shorten healing time.
Long periods of sitting or low movement reduce peripheral circulation and may increase flare frequency. Gentle, regular hand and foot movement supports blood flow and recovery.
Constrictive socks, gloves, or shoes limit microcirculation and increase pressure on fragile skin. Choosing roomier, cushioned layers helps maintain perfusion and reduce friction injury.
Leaving hands or feet damp after washing weakens the skin barrier and can aggravate lesions. Patting dry and applying emollients protects skin integrity and comfort.
Risk prevention
Chilblain lupus can flare when skin gets cold and damp, especially on fingers and toes, making daily tasks uncomfortable. Keeping steady warmth and good circulation usually matters more than chasing temperatures. Different people need different prevention strategies—there’s no single formula. Work with your care team to tailor steps to your climate, routines, and any related conditions like Raynaud’s.
Keep hands, feet, and ears warm with insulated gloves, socks, and hats. Aim for layers that trap heat without sweating. Avoid tight gear that slows blood flow.
Choose moisture-wicking socks and gloves to keep skin dry. Dampness plus cold can trigger chilblain lupus. Change out of wet clothing promptly.
Warm up slowly after being outdoors. Use lukewarm water or room heat, not hot pads or direct heat, which can irritate skin. Sudden temperature swings may worsen chilblain lupus.
Nicotine narrows blood vessels and impairs skin healing. Quitting smoking and avoiding secondhand smoke can lower flares of chilblain lupus.
Transmission
Chilblain lupus is not contagious; you can’t “catch” it from someone else, and it doesn’t spread through touch, shared items, or the air. Most people with chilblain lupus do not have a family history—it’s an autoimmune skin problem that flares with cold, damp conditions, not an infection. In a small number of families, how chilblain lupus is inherited can follow a single‑gene pattern: in some families, one changed copy from an affected parent gives each child about a 50% chance; in others, both parents must carry a silent change, giving each child a 25% chance. New gene changes can also arise for the first time in a child, so the genetic transmission of chilblain lupus isn’t always tied to family history. If you’re planning a family, a genetics professional can explain your specific chances.
When to test your genes
Consider genetic testing if you developed chilblain lupus at a young age, have recurrent cold-triggered lesions with a family history of similar problems, or show signs suggesting monogenic interferonopathies. Testing helps confirm diagnosis, guide targeted therapies, and inform screening for complications. Discuss timing with a clinician during flares or before starting immunomodulators.
Diagnosis
Chilblain lupus can show up as painful, red‑purple patches on fingers, toes, ears, or the nose after cold, damp weather, making simple tasks like texting, buttoning clothes, or walking outside uncomfortable. Doctors usually begin with a careful conversation and skin check to see how your symptoms behave in the cold and whether they fit this pattern. The diagnosis of Chilblain lupus often combines what the skin looks like, when flares happen, and a few targeted tests. This helps separate it from common chilblains, frostbite, Raynaud’s, or other skin conditions.
Your provider asks about timing, cold exposure, and how long spots last. They’ll also review any joint pain, mouth sores, fevers, or sun sensitivity. A family or personal history of autoimmune disease can add important clues.
The doctor looks closely at color, shape, and location of lesions on fingers, toes, ears, or the nose. Photos from recent flares can help if your skin is clear on exam. Distinct patterns raise or lower suspicion for chilblain lupus.
You’ll be asked about weather, indoor cooling, and activities that bring on flares. Discussing gloves, socks, and time outdoors helps connect symptoms to cold and damp exposure. From here, the focus shifts to confirming or ruling out possible causes.
Short notes about when spots appear, how they feel, and what helps can be valuable. Tracking temperature, time outside, and healing time shows patterns that support or argue against chilblain lupus. Photos with dates are especially useful.
Stages of Chilblain lupus
Chilblain lupus does not have defined progression stages. It often flares in cold, damp weather and eases with warmth, so symptoms tend to come and go rather than follow a steady decline. Diagnosis focuses on what shows up on your skin—including early symptoms of chilblain lupus like painful, itchy red‑purple patches on fingers or toes—plus a careful exam, and sometimes a small skin sample (biopsy) to rule out similar conditions. Different tests may be suggested to help confirm the diagnosis and check for related autoimmune conditions.
Outlook and prognosis
Cold snaps, tight shoes, or a long day on your feet can bring chilblain lupus flares to the surface—tender purple-red patches on fingers, toes, ears, or heels that sting or itch and sometimes crack. Many people ask, “What does this mean for my future?”, especially when early symptoms of chilblain lupus overlap with common winter chilblains. For many, skin-only disease stays localized and manageable with cold protection, smoking cessation, and medicines that calm inflammation or improve blood flow. Doctors call this the prognosis—a medical word for likely outcomes.
The outlook is not the same for everyone, but most people with chilblain lupus do not develop life-threatening complications. A smaller group will see symptoms recur each winter or with damp cold, and some may develop scarring or nail changes if lesions are deep or repeated. A minority eventually shows features of systemic lupus over time; this risk is higher if blood tests reveal certain autoantibodies or if there are symptoms beyond the skin, like joint pain, mouth sores, or persistent fatigue. In medical terms, the long-term outlook is often shaped by both genetics and lifestyle.
Serious complications such as ulcers that get infected or, rarely, tissue damage are uncommon when flares are treated early and circulation is protected. Mortality from chilblain lupus itself is very low; when deaths occur in the broader lupus spectrum, they are usually linked to organ involvement that is not typical of skin-limited chilblain lupus. With ongoing care, many people maintain work, exercise, and outdoor time by planning around weather, layering clothing, and using hand and foot warmers. Talk with your doctor about what your personal outlook might look like, including how to spot warning signs of systemic symptoms and when to adjust treatment.
Long-term effects
Chilblain lupus often follows a chronic, on‑and‑off pattern, with cold-triggered skin flares on fingers, toes, ears, or nose. For many, lesions heal between seasons but can leave lasting color changes or tender spots. Long-term effects vary widely, and many people continue working, studying, and staying active with the right care. Flares may return in colder months even after early symptoms of Chilblain lupus fade.
Lesions often return in winter or with damp cold exposure. Warmer weather usually brings relief, but the cycle can repeat year after year.
Spots can leave darker or lighter patches after they heal. Some people with Chilblain lupus notice thin scars or persistent redness on fingers or toes.
Affected areas can sting, itch, or burn when temperatures drop. Over time, even brief cold exposure may trigger discomfort.
Deeper sores can form on fingertips, heels, or ears during severe flares. These can take weeks to heal and may reopen with new cold snaps.
How is it to live with Chilblain lupus?
Living with chilblain lupus often means planning your day around the cold: keeping hands and feet warm, layering socks and gloves even indoors, and pausing activities when burning, itching, or tender skin spots flare after exposure. On workdays or school runs, standing outside or handling cold objects can trigger painful lesions that make typing, walking, or wearing shoes uncomfortable until warmth and medication calm things down. Many find they lean on family or coworkers for practical help on frigid days and may skip outdoor plans in winter, which can strain routines but also leads to shared problem-solving—warming stations at home, pocket hand warmers, and a bit more patience from everyone. With good skin care, protection from cold and damp, and guidance from a clinician, most people learn patterns that let them stay active while preventing or easing flares.
Treatment and drugs
Treatment for chilblain lupus focuses on easing skin inflammation, healing sores, and preventing new flares, especially in cold, damp weather. Doctors sometimes recommend a combination of lifestyle changes and drugs: keeping hands and feet warm and dry, avoiding sudden cold exposure, using moisturizers, and applying prescription anti‑inflammatory creams or ointments to calm lesions. When skin symptoms are widespread or keep returning, oral medicines such as hydroxychloroquine are commonly used; some people may also need short courses of anti‑inflammatory pills, calcium channel blockers to improve blood flow, or other immune‑modulating drugs if first-line options don’t help. Supportive care can make a real difference in how you feel day to day, including gentle wound care for cracks or sores and prompt treatment if there are signs of infection. Your doctor can help weigh the pros and cons of each option and will monitor for side effects and, in some cases, check for signs of systemic lupus to guide long‑term care.
Non-drug treatment
Non-drug care for Chilblain lupus focuses on keeping skin warm and dry, protecting fragile areas, and supporting circulation to reduce flares. Alongside medicines, non-drug therapies can improve day-to-day comfort and help lesions heal. Noticing early symptoms of Chilblain lupus—like redness, itch, or burning in cold, damp weather—lets you act quickly with warmth and skin care to prevent worsening.
Limit time in cold, windy, or damp conditions. Plan errands for warmer parts of the day and seek sheltered routes. Sudden temperature swings can trigger flares.
Wear warm socks, gloves, and layers that trap heat, including thermal liners. Choose breathable, moisture-wicking fabrics to avoid damp skin. Battery-heated gloves or insoles can help in severe cold.
Warm hands and feet slowly with lukewarm water or warm packs, not direct heat. Avoid hot water bottles or heaters on bare skin to prevent burns. Gradual warming is kinder to Chilblain lupus–affected skin.
Change out of wet gloves and socks promptly. Use moisture-wicking liners and rotate footwear so shoes fully dry between uses. Damp skin increases irritation and breakdown.
Your genes may have an impact on how drugs work for you
Some drugs for chilblain lupus work differently depending on gene variants that affect how your body processes medicines, especially immune‑modulating and anti‑inflammatory treatments. Genetics can change drug levels, side‑effect risk, and response, so clinicians may adjust doses or consider alternatives.
Pharmacological treatments
Treatment focuses on calming skin inflammation, easing pain, and preventing new cold-triggered sores. Not everyone responds to the same medication in the same way. Options range from prescription creams to pills that improve blood flow or quiet the immune system. If early symptoms of chilblain lupus keep returning each winter, medicines can help reduce the number and severity of flares.
High-potency corticosteroid creams or ointments such as clobetasol or betamethasone can reduce redness, swelling, and itch. They are used for short courses on active sores to limit skin thinning.
Tacrolimus or pimecrolimus can calm inflammation without the skin-thinning risk of steroids. A brief burning or stinging sensation is common at first and usually eases with continued use.
This antimalarial medicine often helps cutaneous lupus in the hands and feet and can reduce new chilblain lesions. Benefits build gradually over several weeks, and regular eye checks are advised during long-term use.
This blood-vessel relaxer can lessen cold-triggered spasms and help prevent new sores. Flushing, headache, or lightheadedness can occur, especially when starting or increasing the dose.
Genetic influences
Beyond cold exposure and immune triggers, genetics can play a meaningful role in chilblain lupus. If you're wondering whether chilblain lupus is hereditary, some families have a single gene change—often in immune-control genes such as TREX1 or SAMHD1—that raises risk. These genes help the body clear leftover DNA and keep antiviral immune signals in balance; when they don’t work properly, the immune system can stay switched on, making skin more sensitive to cold. Having a gene change doesn’t always mean you will develop the condition. When a single gene is involved, the pattern is usually autosomal dominant, meaning a parent with the change has a 1 in 2 (50%) chance of passing it on, but symptoms can vary widely—even within the same family. Many others have sporadic chilblain lupus without a clear single-gene cause, where inherited tendencies, environment, and immune responses likely interact. Genetic testing for chilblain lupus may be considered, especially when symptoms start in childhood or several relatives are affected, and results can guide care and family planning.
Is Chilblain lupus genetic?
Genetics play a meaningful role in chilblain lupus. Variants in genes affecting immune signaling and skin’s response to cold, like TREX1, can raise risk, especially with family history. Testing is considered when symptoms start early or are severe or recurrent.
Pharmacogenetics—how genetics influence drug effects
In some families, chilblain lupus is tied to inherited changes that push the immune system’s interferon pathway into a higher gear, which can influence which treatments are most helpful. When this pattern is suspected or confirmed (for example, due to changes in genes known medically as TREX1 or SAMHD1), doctors may consider medicines that calm that pathway, such as a targeted class called JAK inhibitors, especially if standard options haven’t worked. Alongside your medical history and other lab results, genetic testing can sometimes identify how your body handles certain drugs, helping to choose safer starting doses. For azathioprine—a medicine sometimes used when skin disease is stubborn—testing for enzyme genes like TPMT or NUDT15 can lower the risk of dangerous drops in blood counts by guiding the dose. If dapsone is considered, checking for G6PD deficiency (an inherited red blood cell trait) helps prevent serious anemia. For commonly used medications for chilblain lupus such as hydroxychloroquine or topical steroids, there isn’t a proven, routine pharmacogenetic test yet, so dosing and choice are based on your overall health, other medicines, and how your skin responds.
Interactions with other conditions
Chilblain lupus can occur on its own or alongside other autoimmune conditions, most often systemic lupus erythematosus (SLE). When SLE is active, the same immune and circulation changes can intensify cold‑triggered sores on the fingers, toes, ears, or nose, and healing may take longer. A condition may “exacerbate” (make worse) symptoms of another. Raynaud’s phenomenon frequently overlaps, and reduced blood flow during a Raynaud’s episode can deepen color changes, swelling, and pain in areas already affected by Chilblain lupus; early symptoms of Chilblain lupus are sometimes mistaken for simple chilblains in this setting. Blood‑clotting antibody conditions, such as antiphospholipid syndrome, and cold‑related problems like cryoglobulinemia can further impair circulation, raising the risk of ulcers or tissue breakdown in severe cases. There is also a genetic form linked to overactive interferon signaling, and some infections can cause chilblain‑like rashes that mimic the condition, so clinicians often check for these overlaps to guide care and reduce complications.
How genes can cause diseases
Humans have more than 20,000 genes, each carrying out one or a few specific functions in the body. One gene instructs the body to digest lactose from milk, another tells the body how to build strong bones and another prevents the body's cells from beginning to multiply uncontrollably and developing into cancer. As all of these genes combined are the building instructions for our body, a defect in one of these genes can have severe health consequences.
Through decades of genetic research, we know the genetic code of any healthy/functional human gene. We have also identified that in certain positions on a gene, some individuals may have a different genetic letter from the one you have. We call these hotspots "Genetic Variations" or "Variants" in short. In many cases, studies have been able to show that having the genetic letter "G" in the position makes you healthy, but having the letter "A" in the same position disrupts the gene function and causes a disease. Genopedia allows you to view these variants in genes and summarizes all that we know from scientific research, which genetic letters (Genotype) have good or bad consequences on your health or on your traits.
History
Throughout history, people have described cold-season sores on fingers and toes that cracked, stung, and took weeks to heal. Families told stories of relatives whose skin would redden and swell every winter, long after others’ chilblains had faded. Looking back, these accounts line up with what we now recognize as chilblain lupus, a form of cutaneous lupus where cold and damp trigger lingering, lupus-related skin inflammation.
First described in the medical literature as stubborn “pernio-like” lesions that didn’t behave like ordinary chilblains, chilblain lupus gradually emerged as its own pattern within lupus skin disease. Early reports focused on the look and timing of the sores—violet patches, tender plaques, and small ulcers on fingers, heels, ears, and sometimes the nose—appearing with cold exposure and persisting into warmer months. From early theories to modern research, the story of chilblain lupus shows how careful observation of seasonal flares helped clinicians separate it from common pernio.
Over time, descriptions became more precise. Doctors noticed that some people with chilblain lupus also had other lupus features, such as photosensitive rashes or mouth sores, while many had only the cold-triggered skin changes. Microscopic examination of biopsies showed patterns typical of cutaneous lupus, which confirmed that these winter-persistent chilblains belonged on the lupus spectrum rather than being simple cold injury.
In recent decades, awareness has grown that chilblain lupus can appear on its own or alongside systemic lupus, and that it may run in families. Advances in genetics linked a rare, inherited form—often beginning in childhood—to changes in the body’s antiviral signaling pathways, which can “overheat” the immune response and make skin especially reactive to cold and damp. These findings did not change treatment overnight, but they clarified why some people develop early symptoms of chilblain lupus and why flares can be so persistent.
Historical differences highlight why naming matters. For years, many lived with repeated winter sores labeled as “severe chilblains,” delaying lupus-focused care. As clinical criteria and skin testing improved, recognition of chilblain lupus led to more tailored advice about cold protection, smoking avoidance, and medicines that calm skin inflammation. Today, clinicians consider both the seasonality and the lupus signature on biopsy when making the diagnosis, reflecting lessons gathered across generations.